TickerGuard
Buy Day today: Neutral (56) Mixed market breadth · major macro event coming up
INVA

Innoviva Inc

Healthcare · Biotechnology

20.70$ +0.4% vs. previous close Closing price · As of: Sep 25, 2026

Statements

Balance Sheet

Innoviva Inc (INVA) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 1,703 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet INVA
Line item Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
1,188 1,244 1,268 1,225 1,232 1,301 1,254 1,334 1,429 1,635 1,837 1,703
305 344 311 358 401 554 582 652 685 728 773 753
180 194 178 217 261 305 319 398 477 551 603 570
180 194 178 217 261 412 447 498 533 551 612 579
68 84 76 94 91 86 78 88 94 35 93 111
41 41 37 37 34 34 41 49 38 39 39 39
18 18 18 18 18 18 18 18 18 18 18 18
237 230 224 217 211 208 202 195 186 182 176 169
561 569 564 559 563 610 607 619 419 462 495 469
36 38 30 28 224 236 235 247 48 50 37 47
1.2 1.2 1.3 1.5 193 194 193 193 8.4 0.4 5.3 0.7
3.8 6.7 0.9 2.0 4.2 2.1 4.7 5.4 6.2 5.0 6.5 4.0
446 446 447 447 256 256 257 257 257 258 258 258
627 675 704 666 669 691 647 715 1,010 1,173 1,342 1,233
-87 -25 11 -23 -22 -1.8 -48 15 105 269 456 373
86 85 85 63 63 84 63 84 85 85 85 73

Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?